Skip to content

Comparing Letrozole and Mifepristone for early pregnancy induced abortions

Comparing Letrozole and Mifepristone pretreatment for medical management of first trimester miscarriages. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092186
Enrollment
150
Registered
2025-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O048- (Induced) termination of pregnancywith other and unspecified complications

Interventions

Intervention1: letrozole: T. Letrozole 10 mg OD for 3 days , followed by 800 mcg of misoprost pv after 72 hours. Control Intervention1: T.MIFEPRISTONE 200 MG: T.Mifepristone 200 mg single dose followe

Sponsors

INHS ASVINI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women more than 21 years of age with 2. Unwanted singleton pregnancies of upto 10 wks.

Exclusion criteria

Exclusion criteria: The exclusion criteria includes history or evidence of adrenal pathology, steroid-dependent cancer, porphyria, poorly controlled hypertension, bronchial asthma, thromboembolism and severe cardiac/renal/liver disease, Haemoglobin level less than 9.5 g/L, presence of an intrauterine contraceptive device, breastfeeding and reported allergic reaction to mifepristone, misoprostol or letrozole

Design outcomes

Primary

MeasureTime frame
The primary outcome is achievement of complete abortionTimepoint: Time taken to achieve complete abortion 1week or 2 week

Secondary

MeasureTime frame
Secondary outcomes include time-to-abortion interval, the number of misoprostol doses required, healthcare resource utilisation and side effects.Timepoint: 2 yrs

Countries

India

Contacts

Public ContactDR SHAZIA KHAN

INSTITUTE OF NAVAL MEDICINE

drshaziakhan@gmail.com9049484689

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026